diseases at the RNA Leader’s Conference in Boston. This conference provides latest advances in RNA chemistry and clinical updates from the companies developing new therapies. Thus, Professor Thum enjoyed great
Sandacrabins - Structurally Unique Antiviral RNA Polymerase Inhibitors from a Rare Myxobacterium. Chemistry 2022;28(10):e202104484 DOI: 10.1002/chem.202104484 Kim Y, Zheng X, Eschke K, Chaudhry MZ, Bertoglio